SMT201400119B - Sintesi di derivati di pirazolincarbossammidina sostituita - Google Patents

Sintesi di derivati di pirazolincarbossammidina sostituita

Info

Publication number
SMT201400119B
SMT201400119B SM201400119T SM201400119T SMT201400119B SM T201400119 B SMT201400119 B SM T201400119B SM 201400119 T SM201400119 T SM 201400119T SM 201400119 T SM201400119 T SM 201400119T SM T201400119 B SMT201400119 B SM T201400119B
Authority
SM
San Marino
Prior art keywords
pyrazolincarboxamidine
synthesis
derivatives
substituted
substituted pyrazolincarboxamidine
Prior art date
Application number
SM201400119T
Other languages
English (en)
Italian (it)
Inventor
Arnold Van Loevezijn
Josephus H M Lange
Gerrit A Barf
Arnold Den P Hartog
Original Assignee
Abbvie Bahamas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Bahamas Ltd filed Critical Abbvie Bahamas Ltd
Publication of SMT201400119B publication Critical patent/SMT201400119B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SM201400119T 2010-01-29 2014-08-29 Sintesi di derivati di pirazolincarbossammidina sostituita SMT201400119B (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29936310P 2010-01-29 2010-01-29
EP10152097 2010-01-29
PCT/EP2011/051100 WO2011092226A1 (en) 2010-01-29 2011-01-27 Synthesis of substituted pyrazoline carboxamidine derivatives
EP11702415.8A EP2528900B1 (en) 2010-01-29 2011-01-27 Synthesis of substituted pyrazoline carboxamidine derivatives

Publications (1)

Publication Number Publication Date
SMT201400119B true SMT201400119B (it) 2014-11-10

Family

ID=42244995

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400119T SMT201400119B (it) 2010-01-29 2014-08-29 Sintesi di derivati di pirazolincarbossammidina sostituita

Country Status (22)

Country Link
US (1) US9422244B2 (xx)
EP (1) EP2528900B1 (xx)
JP (1) JP5792195B2 (xx)
KR (1) KR20120129929A (xx)
CN (1) CN102725272B (xx)
AR (1) AR079935A1 (xx)
AU (1) AU2011209372B2 (xx)
CA (1) CA2787289A1 (xx)
DK (1) DK2528900T3 (xx)
ES (1) ES2485891T3 (xx)
HK (1) HK1174638A1 (xx)
HR (1) HRP20140655T1 (xx)
MX (1) MX2012008798A (xx)
PL (1) PL2528900T3 (xx)
PT (1) PT2528900E (xx)
RS (1) RS53498B1 (xx)
RU (1) RU2550694C2 (xx)
SG (1) SG182635A1 (xx)
SI (1) SI2528900T1 (xx)
SM (1) SMT201400119B (xx)
TW (1) TWI547485B (xx)
WO (1) WO2011092226A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105665148B (zh) * 2016-01-15 2018-05-04 中南大学 一种异硫氰酸酯衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156007A (en) 1974-07-12 1979-05-22 U.S. Philips Corporation Pyrazoline compounds
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
JPS608211A (ja) 1983-06-28 1985-01-17 Showa Denko Kk 農園芸用殺菌剤
JPH062742B2 (ja) * 1987-06-17 1994-01-12 三井東圧化学株式会社 新規2‐ピラゾリン類及びそれを有効成分とする脳血管障害治療剤
SI1373216T1 (en) 2001-03-22 2005-06-30 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
KR100950430B1 (ko) * 2001-09-21 2010-04-02 솔베이 파마슈티칼스 비. 브이 효력있는 cb1-길항 작용을 가지는4,5-디하이드로-1h-피라졸 유도체
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
AU2006328483A1 (en) 2005-12-20 2007-06-28 Solvay Pharmaceuticals B.V. 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TW200730500A (en) 2005-12-20 2007-08-16 Solvay Pharm Bv 4, 5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TWI428334B (zh) 2006-09-22 2014-03-01 Abbvie Bahamas Ltd 作為5-ht6拮抗劑之磺醯基吡唑及磺醯基吡唑啉的甲脒衍生物
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
AR070898A1 (es) * 2008-03-18 2010-05-12 Solvay Pharm Bv Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6
RU2374233C1 (ru) 2008-05-19 2009-11-27 Государственное образовательное учреждение высшего профессионального образования "Российский химико-технологический университет им. Д.И. Менделеева" (РХТУ им. Д.И. Менделеева) ЗАМЕЩЕННЫЕ 2-ТИОКАРБАМОИЛ-3-ФЕНИЛ-3,3а,4,5,6,7-ГЕКСАГИДРО-2Н-ИНДАЗОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ФУНГИЦИДНАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
TW201010981A (en) 2008-08-01 2010-03-16 Solvay Pharm Bv Synthesis of 3,4-diaryl-4,5-dihydro-(1H)-pyrazole-1-carboxamidine derivatives

Also Published As

Publication number Publication date
RU2550694C2 (ru) 2015-05-10
CN102725272B (zh) 2015-07-15
WO2011092226A1 (en) 2011-08-04
SG182635A1 (en) 2012-08-30
JP2013518080A (ja) 2013-05-20
JP5792195B2 (ja) 2015-10-07
MX2012008798A (es) 2012-08-17
HRP20140655T1 (hr) 2014-10-10
ES2485891T3 (es) 2014-08-14
DK2528900T3 (da) 2014-08-25
RU2012136831A (ru) 2014-03-10
PL2528900T3 (pl) 2014-10-31
AU2011209372B2 (en) 2015-06-04
AU2011209372A1 (en) 2012-08-30
US9422244B2 (en) 2016-08-23
SI2528900T1 (sl) 2014-09-30
CA2787289A1 (en) 2011-08-04
US20130060041A1 (en) 2013-03-07
CN102725272A (zh) 2012-10-10
WO2011092226A8 (en) 2012-09-07
PT2528900E (pt) 2014-08-29
TW201125852A (en) 2011-08-01
RS53498B1 (en) 2015-02-27
TWI547485B (zh) 2016-09-01
EP2528900A1 (en) 2012-12-05
KR20120129929A (ko) 2012-11-28
AR079935A1 (es) 2012-02-29
EP2528900B1 (en) 2014-06-11
HK1174638A1 (en) 2013-06-14

Similar Documents

Publication Publication Date Title
SMT201600198B (it) Derivati di 1,2,4-triazina-4-ammina
LTC2620436I2 (lt) Pakeistojo policiklinio karbamoilpiridono darinio provaistas
SMT201600099B (it) Derivati citotossici di benzodiazepine
SMT201700094B (it) Composto di pirazina carbossammide
SMT201600298B (it) Derivati n3-sostituiti-n1-solfonil-5- fluoropirimidinone
SMT201500270B (it) Derivati di pirrolotriazinone come inibitori di pi3k
SMT201500316B (it) Derivati di benzotiazolo come agenti anticancro
SMT201600108B (it) Derivato di pirazochinolina come inibitori di pde9
SMT201600370B (it) Complessi chelati di oligonucleotidi
SMT201600338B (it) Formulazioni farmaceutiche comprendenti derivati di1-(beta-d- glucopiranosil)- 2-tienilmetilbenzene come inibitori di sglt
BR112014003878A2 (pt) síntese de r-bifenilalaninol
DK2590974T3 (da) Tetrahydropyridopyrimidinderivater
SMT201600076B (it) Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
ECSP12011999A (es) Derivados benzamida sustituidos
AR092198A1 (es) Derivados de pirazolopirimidinas
SMT201300067B (it) Applicazioni terapeutiche di derivati di chinazolindione
SMT201600031B (it) Composti eterociclici di fenossimetile
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
SMT201400080B (it) Derivati di pirazinoossazepina
SMT201600405B (it) Derivati di arilalchilamminocarbossammide fluorurati
SMT201500113B (it) Processp per preparare derivati di alfa-carbossammide
DK2571843T3 (da) Forbedret fremstilling af chalcon-derivater
SMT201500067B (it) Derivati di acilbenzene
SMT201500035B (it) Sintesi di aliskiren